The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population

Publisher： Karger

E-ISSN： 1421-9786|27|6|608-613

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.27, Iss.6, 2009-04, pp. : 608-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale and Design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 3, 2009-05 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 5, 2009-04 ,pp. : 509-518

Karger

Access to resources Recommend Favorite

Risk of Recurrent Cerebrovascular Events in Patients with Cryptogenic Stroke or Transient Ischemic Attack and Patent Foramen Ovale: The FORI (Foramen Ovale Registro Italiano) Study

By  

Cerebrovascular Diseases, Vol. 31, Iss. 2, 2010-11 ,pp. : 109-116

Karger

Access to resources Recommend Favorite

Incidence and Predictors of Ischemic Stroke Events during Hospitalization in Patients with Transient Ischemic Attack

By  

Cerebrovascular Diseases, Vol. 37, Iss. 5, 2014-06 ,pp. : 330-335

Karger

Access to resources Recommend Favorite

Transient Ischemic Attack and Minor Stroke Are the Most Common Manifestations of Acute Cerebrovascular Disease: A Prospective, Population-Based Study – The Aarhus TIA Study

By  

Neuroepidemiology, Vol. 40, Iss. 1, 2012-10 ,pp. : 50-55

Karger

Access to resources Recommend Favorite